Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes

J. P. Sarkey, M. Chu, M. McShane, E. Bovo, Y. Ait Mou, A. V. Zima, P. P. de Tombe, G. L. Kartje, J. L. Martin

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Programmed cell death of cardiomyocytes following myocardial ischemia increases biomechanical stress on the remaining myocardium, leading to myocardial dysfunction that may result in congestive heart failure or sudden death. Nogo-A is well characterized as a potent inhibitor of axonal regeneration and plasticity in the central nervous system, however, the role of Nogo-A in non-nervous tissues is essentially unknown. In this study, Nogo-A expression was shown to be significantly increased in cardiac tissue from patients with dilated cardiomyopathy and from patients who have experienced an ischemic event. Nogo-A expression was clearly associated with cardiomyocytes in culture and was localized predominantly in the endoplasmic reticulum. In agreement with the findings from human tissue, Nogo-A expression was significantly increased in cultured neonatal rat cardiomyocytes subjected to hypoxia/reoxygenation. Knockdown of Nogo-A in cardiomyocytes markedly attenuated hypoxia/reoxygenation-induced apoptosis, as indicated by the significant reduction of DNA fragmentation, phosphatidylserine translocation, and caspase-3 cleavage, by a mechanism involving the preservation of mitochondrial membrane potential, the inhibition of ROS accumulation, and the improvement of intracellular calcium regulation. Together, these data demonstrate that knockdown of Nogo-A may serve as a novel therapeutic strategy to prevent the loss of cardiomyocytes following ischemic/hypoxic injury.

Original languageEnglish
Pages (from-to)1044-1055
Number of pages12
JournalJournal of Molecular and Cellular Cardiology
Volume50
Issue number6
DOIs
Publication statusPublished - 1 Jun 2011
Externally publishedYes

Fingerprint

Cardiac Myocytes
Apoptosis
Mitochondrial Membrane Potential
Phosphatidylserines
Dilated Cardiomyopathy
DNA Fragmentation
Sudden Death
Caspase 3
Endoplasmic Reticulum
Myocardial Ischemia
Regeneration
Myocardium
Cell Death
Central Nervous System
Heart Failure
Hypoxia
Calcium
Wounds and Injuries
Therapeutics

Keywords

  • Cell death
  • Ischemic cardiomyopathy
  • Myocardial infarction
  • Reticulon-4A
  • Sarcoplasmic/endoplasmic reticulum

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes. / Sarkey, J. P.; Chu, M.; McShane, M.; Bovo, E.; Mou, Y. Ait; Zima, A. V.; de Tombe, P. P.; Kartje, G. L.; Martin, J. L.

In: Journal of Molecular and Cellular Cardiology, Vol. 50, No. 6, 01.06.2011, p. 1044-1055.

Research output: Contribution to journalArticle

Sarkey, JP, Chu, M, McShane, M, Bovo, E, Mou, YA, Zima, AV, de Tombe, PP, Kartje, GL & Martin, JL 2011, 'Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes', Journal of Molecular and Cellular Cardiology, vol. 50, no. 6, pp. 1044-1055. https://doi.org/10.1016/j.yjmcc.2011.03.004
Sarkey, J. P. ; Chu, M. ; McShane, M. ; Bovo, E. ; Mou, Y. Ait ; Zima, A. V. ; de Tombe, P. P. ; Kartje, G. L. ; Martin, J. L. / Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes. In: Journal of Molecular and Cellular Cardiology. 2011 ; Vol. 50, No. 6. pp. 1044-1055.
@article{639399d96f9c4669a18f2fd1dc752a86,
title = "Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes",
abstract = "Programmed cell death of cardiomyocytes following myocardial ischemia increases biomechanical stress on the remaining myocardium, leading to myocardial dysfunction that may result in congestive heart failure or sudden death. Nogo-A is well characterized as a potent inhibitor of axonal regeneration and plasticity in the central nervous system, however, the role of Nogo-A in non-nervous tissues is essentially unknown. In this study, Nogo-A expression was shown to be significantly increased in cardiac tissue from patients with dilated cardiomyopathy and from patients who have experienced an ischemic event. Nogo-A expression was clearly associated with cardiomyocytes in culture and was localized predominantly in the endoplasmic reticulum. In agreement with the findings from human tissue, Nogo-A expression was significantly increased in cultured neonatal rat cardiomyocytes subjected to hypoxia/reoxygenation. Knockdown of Nogo-A in cardiomyocytes markedly attenuated hypoxia/reoxygenation-induced apoptosis, as indicated by the significant reduction of DNA fragmentation, phosphatidylserine translocation, and caspase-3 cleavage, by a mechanism involving the preservation of mitochondrial membrane potential, the inhibition of ROS accumulation, and the improvement of intracellular calcium regulation. Together, these data demonstrate that knockdown of Nogo-A may serve as a novel therapeutic strategy to prevent the loss of cardiomyocytes following ischemic/hypoxic injury.",
keywords = "Cell death, Ischemic cardiomyopathy, Myocardial infarction, Reticulon-4A, Sarcoplasmic/endoplasmic reticulum",
author = "Sarkey, {J. P.} and M. Chu and M. McShane and E. Bovo and Mou, {Y. Ait} and Zima, {A. V.} and {de Tombe}, {P. P.} and Kartje, {G. L.} and Martin, {J. L.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1016/j.yjmcc.2011.03.004",
language = "English",
volume = "50",
pages = "1044--1055",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes

AU - Sarkey, J. P.

AU - Chu, M.

AU - McShane, M.

AU - Bovo, E.

AU - Mou, Y. Ait

AU - Zima, A. V.

AU - de Tombe, P. P.

AU - Kartje, G. L.

AU - Martin, J. L.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Programmed cell death of cardiomyocytes following myocardial ischemia increases biomechanical stress on the remaining myocardium, leading to myocardial dysfunction that may result in congestive heart failure or sudden death. Nogo-A is well characterized as a potent inhibitor of axonal regeneration and plasticity in the central nervous system, however, the role of Nogo-A in non-nervous tissues is essentially unknown. In this study, Nogo-A expression was shown to be significantly increased in cardiac tissue from patients with dilated cardiomyopathy and from patients who have experienced an ischemic event. Nogo-A expression was clearly associated with cardiomyocytes in culture and was localized predominantly in the endoplasmic reticulum. In agreement with the findings from human tissue, Nogo-A expression was significantly increased in cultured neonatal rat cardiomyocytes subjected to hypoxia/reoxygenation. Knockdown of Nogo-A in cardiomyocytes markedly attenuated hypoxia/reoxygenation-induced apoptosis, as indicated by the significant reduction of DNA fragmentation, phosphatidylserine translocation, and caspase-3 cleavage, by a mechanism involving the preservation of mitochondrial membrane potential, the inhibition of ROS accumulation, and the improvement of intracellular calcium regulation. Together, these data demonstrate that knockdown of Nogo-A may serve as a novel therapeutic strategy to prevent the loss of cardiomyocytes following ischemic/hypoxic injury.

AB - Programmed cell death of cardiomyocytes following myocardial ischemia increases biomechanical stress on the remaining myocardium, leading to myocardial dysfunction that may result in congestive heart failure or sudden death. Nogo-A is well characterized as a potent inhibitor of axonal regeneration and plasticity in the central nervous system, however, the role of Nogo-A in non-nervous tissues is essentially unknown. In this study, Nogo-A expression was shown to be significantly increased in cardiac tissue from patients with dilated cardiomyopathy and from patients who have experienced an ischemic event. Nogo-A expression was clearly associated with cardiomyocytes in culture and was localized predominantly in the endoplasmic reticulum. In agreement with the findings from human tissue, Nogo-A expression was significantly increased in cultured neonatal rat cardiomyocytes subjected to hypoxia/reoxygenation. Knockdown of Nogo-A in cardiomyocytes markedly attenuated hypoxia/reoxygenation-induced apoptosis, as indicated by the significant reduction of DNA fragmentation, phosphatidylserine translocation, and caspase-3 cleavage, by a mechanism involving the preservation of mitochondrial membrane potential, the inhibition of ROS accumulation, and the improvement of intracellular calcium regulation. Together, these data demonstrate that knockdown of Nogo-A may serve as a novel therapeutic strategy to prevent the loss of cardiomyocytes following ischemic/hypoxic injury.

KW - Cell death

KW - Ischemic cardiomyopathy

KW - Myocardial infarction

KW - Reticulon-4A

KW - Sarcoplasmic/endoplasmic reticulum

UR - http://www.scopus.com/inward/record.url?scp=79955671190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955671190&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2011.03.004

DO - 10.1016/j.yjmcc.2011.03.004

M3 - Article

VL - 50

SP - 1044

EP - 1055

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 6

ER -